Bill & Melinda Gates Foundation grant for TropiQ

Dechering, Koen

TropIQ Health Sciences receives a grant from the Bill & Melinda Gates Foundation for  groundbreaking malaria research. On the photo Dr. Koen Dechering, Chief Executive Officer of TropIQ Health Sciences.

TropIQ, a spin-off of company of the UMC St Radboud, has won a Grand Challenges Explorations award, an initiative funded by the Bill & Melinda Gates Foundation. With this grant, TropIQ will develop a high throughput mosquito screen to identify novel types of malaria-eradicating drugs. The winning idea entails the use of luminescent malaria parasites and molecular barcodes for hit deconvolution in large scale mosquito infectivity screens. Out of hundreds of applications from all over the world, TropIQ's idea was selected as one of twelve groundbreaking proposals to accelerate the eradication of malaria. The winners receive 100.000 US dollar to put their idea to the test. In a second phase, 1.000.000 US dollar is available for further development of successful proposals.

"We continue to be impressed by the novelty and innovative spirit of Grand Challenges Explorations projects and are enthusiastic about this exciting research," said Chris Wilson, director of Global Health Discovery and Translational Sciences at the Bill & Melinda Gates Foundation. "These investments hold real potential to yield new solutions to improve the health of millions of people in the developing world, and ensure that everyone has the chance to live a healthy productive life."

 

 


<< back to overview news items